Promazine

from Wikipedia, the free encyclopedia
Structural formula
Structure of promazine
General
Non-proprietary name Promazine
other names

N , N -dimethyl-3- (10 H -phenothiazin-10-yl) propan-1-amine

Molecular formula C 17 H 20 N 2 S
External identifiers / databases
CAS number
PubChem 4926
DrugBank DB00420
Wikidata Q419822
Drug information
ATC code

N05 AA03

Drug class

Antipsychotic

properties
Molar mass 284.42 g mol −1
Physical state

firmly

Melting point
  • 155-158 ° C
  • 177-181 ° C (hydrochloride)
boiling point

203-210 ° C (40 Pa )

pK s value

9.4

safety instructions
Please note the exemption from the labeling requirement for drugs, medical devices, cosmetics, food and animal feed
GHS labeling of hazardous substances

Hydrochloride

07 - Warning

Caution

H and P phrases H: 302-317
P: 280-301 + 312 + 330
Toxicological data
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Promazine is a heterocyclic , aromatic compound from the group of thiazines and the basic substance of Promazine . It is a weakly potent, classic neuroleptic from the group of phenothiazines . It was patented by Rhône-Poulenc in 1950 . As a medicinal substance , it was previously marketed in Germany under the names Protactyl and Sinophenin . It is one of the oldest drugs used to treat schizophrenia , but has been largely supplanted by newer drugs.

indication

Psychotic states. Manic phase in bipolar disorder . Psychomotor restlessness and tension, e.g. B. during alcohol withdrawal. Specific forms of nausea and nausea where first-line drugs are contraindicated or do not produce the expected effect.

Mechanism of action

Like all phenothiazines, promazine blocks a whole range of receptors for neurotransmitters , such as D 2 -, α 1 -, 5-HT 2 -, H 1 - and M 1 receptors, causing an antipsychotic , sedative , anti- adrenergic , antihistaminic , anticholinergic , ganglion-blocking , antiemetic and local anesthetic effects can arise. Promazin also acts as a FIASMA (functional inhibitor of acid sphingomyelinase ).

unwanted effects

As with all classic neuroleptics, extrapyramidal motor effects can occur during treatment with promazine .

Daytime sleepiness, dry mouth and blood pressure fluctuations as well as micturition disorders , constipation and tachycardia often occur . These undesirable effects ( side effects ) disappear in the course of treatment with Promazine or can be reduced by reducing the dose .

Haematopoiesis , cholestasis , endocrine disorders, eczema and photosensitization are less common, and seizures or glaucoma formation have also been observed in individual cases . Also dyskinesia after prolonged treatment and tardive dyskinesia can occur.

A neuroleptic malignant syndrome with fever , muscle stiffness and decreased consciousness develop very rarely .

Long-term treatment and / or high doses of promazine can cause deposits in the cornea and lens of the eye .

Trade names

Prazine (CH), Protactyl (D, there are no longer any promazine preparations in Germany and Austria). Is still prescribed by doctors in Switzerland (Promazine HCI).

See also

Individual evidence

  1. ^ Brockhaus ABC Chemie , VEB FA Brockhaus Verlag. Leipzig 1965, p. 1135.
  2. a b c d e f Entry on Promazin. In: Römpp Online . Georg Thieme Verlag, accessed on July 25, 2019.
  3. a b Data sheet Promazine hydrochloride from Sigma-Aldrich , accessed on May 14, 2017 ( PDF ).
  4. compendium.ch , see under Prazine®.
  5. Kornhuber J, Muehlbacher M, Trapp S, Pechmann S, Friedl A, Reichel M, Mühle C, Terfloth L, Groemer T, Spitzer G, Liedl K, Gulbins E, Tripal P: Identification of novel functional inhibitors of acid sphingomyelinase . In: PLoS ONE . 6, No. 8, 2011, p. E23852. doi : 10.1371 / journal.pone.0023852 .
  6. Walter Schunack: Medicines. Springer-Verlag, 2013, ISBN 978-3-322-83553-6 , p. 139 ( limited preview in the Google book search).